These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 11221875

  • 1. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
    Son YI, Dallal RM, Mailliard RB, Egawa S, Jonak ZL, Lotze MT.
    Cancer Res; 2001 Feb 01; 61(3):884-8. PubMed ID: 11221875
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT, Grant AJ, Siegel JP.
    J Immunol; 1995 May 15; 154(10):5093-102. PubMed ID: 7730615
    [Abstract] [Full Text] [Related]

  • 3. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood.
    Lü HZ, Zhu AY, Chen Y, Tang J, Li BQ.
    Hum Immunol; 2011 Jul 15; 72(7):538-46. PubMed ID: 21540068
    [Abstract] [Full Text] [Related]

  • 4. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR, Renauld JC, Houssiau FA.
    Cytokine; 1999 Nov 15; 11(11):822-30. PubMed ID: 10547269
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M, Jewett A.
    Cancer Detect Prev; 2000 Nov 15; 24(4):314-24. PubMed ID: 11059563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential effect of interleukin 10 on interleukin 12- and interleukin 2-mediated killer induction from blood mononuclear cells.
    Pai K, Yanagawa H, Takauchi E, Suzuki Y, Hanibuchi M, Parajuli P, Sone S.
    Oncol Res; 1998 Nov 15; 10(6):295-300. PubMed ID: 9848100
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
    Redlinger RE, Mailliard RB, Lotze MT, Barksdale EM.
    J Pediatr Surg; 2003 Mar 15; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
    [Abstract] [Full Text] [Related]

  • 12. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
    Wong PY, Staren ED, Tereshkova N, Braun DP.
    J Surg Res; 1998 Apr 15; 76(1):95-103. PubMed ID: 9695747
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J.
    Arthritis Rheum; 2003 Mar 15; 48(3):780-90. PubMed ID: 12632433
    [Abstract] [Full Text] [Related]

  • 15. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro.
    Kelly-Rogers J, Madrigal-Estebas L, O'Connor T, Doherty DG.
    Hum Immunol; 2006 Nov 15; 67(11):863-73. PubMed ID: 17145366
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M.
    Hum Immunol; 2004 Nov 15; 65(11):1377-88. PubMed ID: 15556688
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS, Cho WK, Yoo J, Seong YR, Kim BK, Kim S, Im DS.
    Cancer Gene Ther; 2004 Jun 15; 11(6):397-407. PubMed ID: 15044962
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells.
    Gruenbacher G, Gander H, Nussbaumer O, Nussbaumer W, Rahm A, Thurnher M.
    Cancer Res; 2010 Dec 01; 70(23):9611-20. PubMed ID: 20947520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.